Ding Ai
Impact in
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology
- Cell Biology top 2%
- Hippo pathway signaling and YAP/TAZ
Papers in
-
- Metabolomics and Mass Spectrometry Studies 4
- Angiogenesis and VEGF in Cancer 4
- Ubiquitin and proteasome pathways 3
- Biochemistry 23
- Eicosanoids and Hypertension Pharmacology 21
- Co-authors
- Yi Zhu (42 shared papers)Xu Zhang (23 shared papers)Jinlong He (18 shared papers)Chunjiong Wang (11 shared papers)Bochuan Li (15 shared papers)Bruce D. Hammock (9 shared papers)Alan R. Tall (7 shared papers)Hongfeng Jiang (13 shared papers)
- Journals
- Circulation Research (10 papers)British Journal of Pharmacology (5 papers)Journal of Clinical Investigation (5 papers)Circulation (4 papers)Clinical and Experimental Pharmacology and Physiology (3 papers)
- Partner nations
- ChinaUnited StatesRomania
In The Last Decade
Ding Ai
84 papers receiving 3.8k citations
Ding Ai's Hit Papers
Peers
Comparison fields: 5 of 122
- Biochemistry 759
- Cell Biology 738
- Endocrinology, Diabetes and Metabolism 420
- Cancer Research 369
- Immunology 433
Countries citing papers authored by Ding Ai
This map shows the geographic impact of Ding Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding Ai more than expected).
Fields of papers citing papers by Ding Ai
This network shows the impact of papers produced by Ding Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding Ai. The network helps show where Ding Ai may publish in the future.
Co-authors
The 25 scholars most cited alongside Ding Ai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow Hit paper breakdown → | 2016 | 521 |
| 2 | Alox15/15-HpETE Aggravates Myocardial Ischemia-Reperfusion Injury by Promoting Cardiomyocyte Ferroptosis Hit paper breakdown → | 2023 | 289 |
| 3 | 2018 | 208 | |
| 4 | 2012 | 166 | |
| 5 | 2012 | 144 | |
| 6 | 2009 | 139 | |
| 7 | 2007 | 136 | |
| 8 | 2010 | 113 | |
| 9 | 2018 | 109 | |
| 10 | 2019 | 109 | |
| 11 | 2020 | 99 | |
| 12 | 2022 | 95 | |
| 13 | 2017 | 93 | |
| 14 | 2012 | 92 | |
| 15 | 2020 | 86 | |
| 16 | 2014 | 85 | |
| 17 | 2016 | 79 | |
| 18 | 2015 | 79 | |
| 19 | 2014 | 69 | |
| 20 | 2015 | 66 |
About Ding Ai
Ding Ai is a scholar working on Molecular Biology, Biochemistry, Cell Biology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 84 papers that have together received 3.8k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (21 papers), Hippo pathway signaling and YAP/TAZ (14 papers), Hormonal Regulation and Hypertension (8 papers), Fatty Acid Research and Health (6 papers), Metabolomics and Mass Spectrometry Studies (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Nitric Oxide and Endothelin Effects (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Biochemistry (759 citations), Cell Biology (738 citations), Endocrinology, Diabetes and Metabolism (420 citations), Cancer Research (369 citations) and Immunology (433 citations). Ding Ai has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Yi Zhu, Xu Zhang, Jinlong He, Chunjiong Wang, Bochuan Li, Bruce D. Hammock, Alan R. Tall, Hongfeng Jiang, Huizhen Lv and Zhipeng Chen. Their work appears in journals such as Circulation Research, British Journal of Pharmacology, Journal of Clinical Investigation, Circulation and Clinical and Experimental Pharmacology and Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.